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Abstract
Because there is no effective antibiotic to eradicate Staphylococcus epidermidis biofilm infections that lead to the failure of
medicaldeviceimplantations,thedevelopmentofanti-biofilmvaccinesisnecessary.BiofilmformationbyS.epidermidisrequires
accumulation-associated protein (Aap) that contains sequence repeats known as G5 domains, which are responsible for the
Zn
2+-dependent dimerization of Aap to mediate intercellular adhesion. Antibodies against Aap have been reported to inhibit
biofilm accumulation. In the present study, three monoclonal antibodies (MAbs) against the Aap C-terminal single B-repeat
construct followed by the 79-aa half repeat (AapBrpt1.5) were generated. MAb18B6 inhibited biofilm formation by S. epidermidis
RP62A to 60% of the maximum, while MAb25C11 and MAb20B9 enhanced biofilm accumulation. All three MAbs aggregated the
planktonic bacteria to form visible cell clusters. Epitope mapping revealed that the epitope of MAb18B6, which recognizes an
identical area within AapBrpt constructs from S. epidermidis RP62A, was not shared by MAb25C11 and MAb20B9. Furthermore, all
three MAbs were found to affect both Aap expression and extracellular polymeric substance (EPS, including extracellular DNA
and PIA) biosynthesis in S. epidermidis and enhance the cell accumulation. These findings contribute to a better understanding
of staphylococcal biofilm formation and will help to develop epitope-peptide vaccines against staphylococcal infections.
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Introduction
Staphylococcus epidermidis, an opportunistic pathogen, has become
one of the most prevalent causes of nosocomial infections, espe-
cially in patients with prosthetic medical devices [1,2]. S. epidermidis
colonization of these devices is complicated by the formation of
biofilms, which render it increasingly resistant to multiple anti-
biotics and host defenses [3,4]. Replacement of the indwelling
medical devices after S. epidermidis biofilm infection is generally
necessary, and the development of biofilm-preventing vaccines is
imperative.
Biofilms are bacterial communities that adhere to biological or
abiotic substrata and are stabilized by extracellular polymeric
substances (EPSs), typically composed of polysaccharides and
extracellular DNA [2,5,6,7,8]. The formation of staphylococcal
biofilms involves two phases: primary adhesion followed by biofilm
accumulation [4,9,10,11]. Once attached to the substrata, the
bacteria will proliferate, secrete and be enmeshed within EPS, and
then accumulate as multilayered cell clusters. Polysaccharide inter-
cellular adhesin (PIA), which is synthesized by proteins encoded in
the ica operon [12,13,14,15,16], and extracellular DNA (eDNA)
released from dead bacteria [6,7,8] have been considered essential
in the process of staphylococcal biofilm accumulation. However,
ica-negative but biofilm-positive staphylococci have recently been
described, with biofilms do not contain PIA but rely solely on
protein-protein interactions [17,18]. Accumulation-associated pro-
tein (Aap) is considered one of the most important proteins that
involved in S. epidermidis biofilm formation. Implicated in both
polysaccharide-based [19] and protein-based [17,20] biofilms, Aap
can directly mediate intercellular adhesion. According to an amino
acid sequence analysis, Aap contains an A region and a B-repeat
region. The A region, containing an N-terminal A-repeat domain
with 11 degenerate 16-aa repeats and a putative globular domain
(‘‘a/b’’), has been found to mediate the adhesion of S. epidermidis to
human corneocytes [21]. The B-repeat region (AapBrpt), com-
posed of a variable number (5 to 17) [20] of nearly identical 128-aa
repeat constructs terminating in a conserved ‘‘half repeat’’ motif,
promotes intercellular adhesion [17,18] through Zn
2+-dependent
dimerization [22].
Antiserum against Aap showed inhibition of both proteinaceous
[17,20] and polysaccharide-based [19] biofilm formation by S.
epidermidis. Biofilm-inhibiting monoclonal antibodies against Aap
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candidate to prevent biofilm infections. In the present study,
mouse monoclonal antibodies (MAbs) raised against the Aap C-
terminal single B-repeat construct followed by the 79-aa half
repeat (AapBrpt1.5), which has been proven to be the basic
functional unit required for Aap to mediate bacterial accumulation
[22], were prepared to locate the epitopes that induce the pro-
duction of anti-biofilm antibodies for the further development of
epitope-peptide vaccines. However, only MAb18B6 inhibited bio-
film formation by S. epidermidis RP62A to 60% of the maximum,
whereas MAb25C11 and MAb20B9 enhanced biofilm accumulation.
Epitope mapping revealed that MAb18B6 recognized an identical
area within all AapBrpt constructs, which was not shared by
MAb25C11 and MAb20B9. The effects of the MAbs on Aap ex-
pression and EPS biosynthesis in S. epidermidis were further studied
to investigate the enhanced biofilm formation and bacterial
accumulation. Our study provides new insights into the mecha-
nisms of staphylococcal biofilm formation and may help in de-
veloping anti-staphylococcal biofilm vaccines.
Results
General characteristics of the MAbs against AapBrpt1.5
To locate the epitopes of the anti-biofilm antibodies, three mouse
monoclonal antibodies against AapBrpt1.5 from S. epidermidis
ATCC 12228 were prepared and termed MAb18B6, MAb25C11,
and MAb20B9. All three MAbs, purified using protein G-Sepharose
from mouse ascites, were identified as IgG. The immunoreactivity
of the MAbs was detected using enzyme-linked immunosorbent
assay (ELISA) and immunoprecipitation. The MAbs bound to
recombinant AapBrpt1.5 with a high affinity (ELISA titers
$1:1,280,000 per 0.4 mg/mL antibody), and the MAbs interacted
with AapBrpt1.5 under both non-denaturing and denaturing
conditions. Moreover, at a low concentration (1 ng/mL), the MAbs
bound specifically to Aap in S. epidermidis, whereas they interacted
with multiple proteins at higher concentrations ($100 ng/mL), as
detected by Western blot (Figure 1).
Anti-AapBrpt1.5 MAbs recognize different epitopes
To locate the epitopes of the MAbs, AapBrpt1.5 (N-terminally
fused to a GB1-His-tag [24,25,26]) was truncated into the fol-
lowing fragments: TF1–160,T F 1–102, and TF1–53 (Figure 2A). The
interactions between truncated fragments and the MAbs were
studied using immunoprecipitation. MAb18B6 interacted with the
truncated fragment TF1–160 but not the others, and MAb25C11 and
MAb20B9 interacted with both TF1–160 and TF1–102 (Figure 2A),
indicating that the recognition site for MAb18B6 is located between
aa 103–160 and the sites for MAb25C11 and MAb20B9 are located
between aa 54–102. In addition, truncated fragments of AapBrpt1.5,
TF1–132,T F 1–122,T F 1–112,T F 1–90,T F 1–80,T F 1–70,a n dT F 1–60,w e r e
prepared for more precise mapping (Figure 2B, C). The precise
epitopes of MAb25C11 and MAb20B9 were located between aa 71–80
(Figure 2B), which are in a non-identical area within AapBrpt
constructs from S. epidermidis RP62A (Figure 2D, E). Regarding
MAb18B6, its recognition site was located within aa 103–122
(Figure 2C), which is identical to the homologous position in all 12
AapBrpt constructs from S. epidermidis RP62A (Figure 2D, E).
Anti-AapBrpt1.5 MAbs affect the biofilm formation by
S. epidermidis
By assaying biofilm formation in polystyrene plates [17,19], all
three MAbs were found to affect the biofilm formation by S.
epidermidis RP62A: MAb18B6 inhibited biofilm formation to 60%
of the maximum, while MAb25C11 and MAb20B9 enhanced the
biofilm accumulation (Figure 3A, B). Twice the molar amount of
AapBrpt1.5 added to the MAbs completely abolished the ability
of the antibodies to affect biofilm formation (Figure 3A). More-
over, normal biofilm of S. epidermidis (with a depth of 4.5 mM) had
a smooth surface and contained proportionally more viable cells
and less dead bacteria (Figure 3C). However, the surface of the
biofilm formed in the presence of MAb18B6 and MAb25C11
(especially MAb18B6) was rough, and the biofilm (with a depth of
6.5 mM) contained many crater-like micropores and thin areas
(Figure 3C). The biofilm formed in the presence of MAb20B9 was
much thicker (10.5 mM) than the untreated one (Figure 3C). All
Figure 1. Antigenic specificity of the MAbs. The antigenic specificities of the MAbs at 1 ng/mL and at higher concentrations (10 ng/mL, 100 ng/
mL) against proteins in supernatants of lysostaphin-treated S. epidermidis RP62A (‘‘RP62A’’) and ATCC 12228 (‘‘12228’’) were analyzed using Western
blot. The multiple proteins (between 250 kDa–300 kDa) in S. epidermidis RP62A, or the single protein (180 kDa) in S. epidermidis ATCC 12228, probed
by 1 ng/mL MAbs, corresponded to full-length or proteolytically processed Aap, based on an analysis of these bands using a 4700 MALDI-TOF/TOF
proteomics analyzer (Applied Biosystems, http://www.appliedbiosystems.com).
doi:10.1371/journal.pone.0020918.g001
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portion of dead cells, as demonstrated using the fluorescence
quantity ratios (Table 1).
In addition to biofilm formation, planktonic bacteria of S.
epidermidis RP62A co-cultivated with the MAbs formed macro-
scopically and microscopically visible cell clusters, and the
aggregation of the cells was initiated at 9 h post-incubation.
Twice the molar amount of AapBrpt1.5 added to the MAbs
abolished the ability of the antibodies to aggregate the bacteria
(Figure 4). To analyze whether the formation of the cell clusters
was due to immune agglutination, the concentration of the MAbs
contained in the bacterial culture was evaluated by SDS-PAGE
(silver staining). The MAbs in bacterial culture was found to be
degraded with time, and it could not be detected after 10 h post-
incubation (data not shown). It indicated that the cell aggregation
was not mediated by immune agglutination because the formation
of the clusters was initiated at 9 h post-incubation while the MAbs
was almost undetected. Moreover, the aggregated planktonic cells
were completely disaggregated upon treatment with proteinase K,
whereas DNase I and sodium-meta-periodate (used to rule out the
involvement of eDNA or polysaccharide, respectively) had less
effect on disintegrating the clusters, suggesting that formation of
the cell clusters might be related to the up-regulated expression of
intercellular adhesion-associated proteins, probably including Aap.
Figure 2. Epitope mapping of anti-AapBrpt1.5 MAbs. AapBrpt1.5 N-terminally fused with a GB1-tagged six-histidine (GB1-His) tag was
truncated into a series of fragments as shown in the schematic diagrams, and the binding ability between the truncated fragments and MAbs was
analyzed using immunoprecipitation. (A) Preliminary epitope mapping. (B) Precise recognition site mapping of MAb25C11 and MAb20B9. (C) Precise
recognition site mapping of MAb18B6. (D) Domain structures of Aap from S. epidermidis RP62A (‘‘RP62A’’) and ATCC 12228 (‘‘12228’’). The A-repeat
region, the putative globular domain (a/b), the B-repeat region containing 6 or 12 tandem Brpt constructs, the collagen-like proline/glycine-rich
region, the domain boundary of AapBrpt1.5, and the MAb epitopes are illustrated. (E) Amino acid sequence alignment of AapBrpt constructs. The
AapBrpt construct in AapBrpt1.5 (GenBank NP_763730) and twelve distinct AapBrpt constructs from S. epidermidis RP62A (RP62A 01-12, GenBank
YP_189945) were aligned using the ClustalW2 program (http://www.ebi.ac.uk/Tools/clustalw2). The identified epitopes of the MAbs are shown in
boxes, and the identical residues are marked with asterisks. The conserved substitutions are represented by ‘‘:’’, and semi-conserved substitutions are
represented by ‘‘.’’. Two conserved His residues in AapBrpt constructs are marked with triangles.
doi:10.1371/journal.pone.0020918.g002
Figure 3. Anti-AapBrpt1.5 MAbs affected biofilm formation by S. epidermidis. (A) Macroscopic profiles of the biofilms cultured in
polystyrene plates. The biofilms were cultured in TSB medium containing each MAb (10 mg/mL, 0.07 mM) alone or both MAbs (10 mg/mL, 0.07 mM)
and AapBrpt1.5 (untagged, 3.2 mg/mL, 0.14 mM). The images represent one of three independent experiments. (B) Anti-AapBrpt1.5 MAbs affected
biofilm formation by S. epidermidis RP62A in a dose-dependent manner. The biofilm formation was measured using crystal violet staining, and the
results are depicted as means 6 SD of three independent experiments. (C) Three-dimensional structures of 14-h-old biofilms. Biofilm formation by S.
epidermidis RP62A in the presence of each MAb (10 mg/mL) was visualized using Live/Dead viability staining (SYTO9/PI) and observed under a
confocal laser scanning microscopy (CLSM). Green fluorescent cells are viable, whereas red fluorescent cells are dead. The images, representing oneo f
three independent experiments, were three-dimensionally reconstructed using Imaris software (Bitplane, http://www.bitplane.com) based on CLSM
data at approximately 0.5 mm increments. ‘‘RP62A’’: untreated, ‘‘Mock’’: normal mouse IgG-treated; white arrows and red arrows indicate thin areas
and crater-like micropores, respectively.
doi:10.1371/journal.pone.0020918.g003
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S. epidermidis
The Aap expression in S. epidermidis RP62A co-cultured with
anti-AapBrpt1.5 MAbs was studied using Western blot and
immunofluorescence. In the absence of the MAbs, planktonic
and biofilm S. epidermidis expressed similar amounts of Aap
(Figure 5), whereas, notably, planktonic cells co-cultured with
the MAbs showed up-regulated Aap expression (Figure 5, 6 and
Table 2). Bacteria in superficial layers of the MAb-treated biofilms
and the cells at the boundaries of crater-like micropores in
MAb18B6-treated biofilm also expressed more Aap (Figure 7 and
Table 3), whereas the Aap expression of bacteria in profound
layers of the biofilms co-incubated with the MAbs was obviously
down-regulated (Figure 5, 7 and Table 3).
Anti-AapBrpt1.5 MAbs affect the eDNA release and PIA
biosynthesis in S. epidermidis
Because eDNA and PIA are essential to staphylococcal biofilm
formation in addition to Aap [6,7,12,13,14,15,16], the biosynthesis
of these two EPSs in biofilms co-cultured with the MAbs was
analyzed. Quantitative PCRs (Q-PCRs) of four chromosomal loci
(gyrA, lueA, lysA, and serp0306) were performed to detect the eDNA
quantity in the biofilms [27,28,29]. The eDNA release from
biofilms formed in the presence of the MAbs (especially for
MAb25C11 and MAb20B9) was obviously up-regulated (Figure 8A).
Furthermore, when treated with DNase I, the biofilm formed in
the presence of the MAbs was more severely disintegrated than
that formed in the absence of the antibodies (Figure 8B, C). The
up-regulated eDNA release was consistent with the higher
proportion of dead cells in biofilms co-cultured with the MAbs
(Table 1). However, no significant Triton X-100-induced autolysis
of S. epidermidis RP62A treated with the MAbs was observed (data
not shown) compared with the untreated one. In addition, PIA
synthesis in biofilms co-cultured with the MAbs was also up-
regulated (Figure 8D), as detected using a wheat germ agglutinin
(WGA)-horseradish peroxidase (HRP) dot blot assay [30,31,32].
Table 1. Fluorescence quantities of the Live/Dead stained
biofilms.
a
MAbs STTO9
b PI
c Total
d PI/Total
e
18B6 745.6 159.0 906.9 0.175
25C11 1010.1 247.2 1258.8 0.196
20B9 1018.3 512.8 1531.1 0.335
Mock 1228.1 205.3 1435.0 0.143
- 1430.5 191.5 1623.4 0.118
a. The biofilm of S. epidermidis RP62A formed in the presence of each MAb
(10 mg/mL) was visualized using Live/Dead viability staining (SYTO9/PI). After
obtaining the 3-D structure of the biofilms under a CLSM (Figure 3), the Z-stack
composite confocal photomicrographs were further generated, and the stacks
of viable cells, dead cells, and both cells (viable & dead) were generated
separately. The fluorescence quantities of SYTO9-stained viable cells and PI-
stained dead cells were determined using ImageJ program (http://rsbweb.nih.
gov/ij).
b. ‘‘SYTO9’’ stands for the fluorescence quantities of the viable cell stacks.
c. ‘‘PI’’ stands for the fluorescence quantities of the dead cell stacks.
d. ‘‘Total’’ represents the fluorescence quantities of both cell stacks.
e. ‘‘PI/Total’’ represents the proportion of the dead cell in the biofilms.
doi:10.1371/journal.pone.0020918.t001
Figure 4. Cell aggregation mediated by the MAbs. S. epidermidis RP62A was statically cultured in TSB medium containing each MAb (10 mg/mL,
0.07 mM) alone or both MAb (10 mg/mL, 0.07 mM) and AapBrpt1.5 (untagged, 3.2 mg/mL, 0.14 mM). The photomicrographs were obtained by a Nikon
TE2000-U inverted microscopy using a 40x objective lens (Nikon, http://www.nikoninstruments.com/). ‘‘RP62A’’: untreated; ‘‘Mock’’: normal mouse
IgG-treated.
doi:10.1371/journal.pone.0020918.g004
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(10 mg/mL) was detected using Western blot with MAb25C11 (1 ng/mL). After separation of the proteins using 7% SDS-PAGE, the gel pieces carrying
high molecular-weight proteins (.130 kDa) were excised for Western blot assay, and the remaining gel was stained using Coomassie brilliant blue as
the endogenous control. (B) Relative transcriptional level. The transcriptional level of aap was detected by Q-RT-PCR using RNA sample extracted
from S. epidermidis RP62A co-cultured with each MAb (10 mg/mL). The housekeeping gene gyrB was used as an endogenous control, and all samples
were analyzed in triplicate and normalized against gyrB transcription (means 6 SD). ‘‘RP62A’’: untreated, ‘‘Mock’’: normal mouse IgG-treated.
doi:10.1371/journal.pone.0020918.g005
Figure 6. Aap expression in planktonic S. epidermidis. Aap expressed in planktonic S. epidermidis RP62A (cultured for 14 h) was probed with
MAb25C11 (10 ng/mL) and Cy3-conjugated secondary antibody (1:100 diluted, red). The bacteria were stained with SYTO9 (1 mM, green) and observed
under a Leica TCS SP5 CLSM. ‘‘NC’’: negative control (the cell clusters formed in the presence of MAb25C11 were probed with Cy3-conjugated
secondary antibody alone to establish that the clusters no longer contained initially added MAb (10 mg/mL), that could cause false-positive
immunofluorescence, after 14 h culture), ‘‘RP62A’’: untreated; ‘‘Mock’’: normal mouse IgG-treated.
doi:10.1371/journal.pone.0020918.g006
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Antibodies against Aap have been shown to inhibit biofilm
formation [17,19,20,23], indicating that Aap may serve as a
vaccine candidate to prevent S. epidermidis biofilm infections
[33,34]. However, full-length Aap is not a safe vaccine for
systemic immunization because such bacterial antigens contain
many antigenic determinants and may induce hypersensitivity
reactions [35,36]. A peptide that induces anti-biofilm humoral
immunity would be an optimal vaccine. Previous studies have
shown that AapBrpt1.5 is the basic functional unit of Aap required
to mediate the bacterial accumulation [22], suggesting that
AapBrpt1.5 should harbor the epitopes that would guide the
development of biofilm-preventing epitope-based peptide vaccines.
Monoclonal antibodies against AapBrpt1.5 were prepared in the
present study to identify these epitopes.
The anti-AapBrpt1.5 MAbs have different effects on
biofilm formation
Because of the difficulties in cloning aapBrpt1.5 from genome of
S. epidermidis RP62A, AapBrpt1.5 from S. epidermidis ATCC 12228,
which shares 92.3% identical residues with that from S. epidermidis
RP62A, was cloned and expressed, and three MAbs against
AapBrpt1.5 were generated. MAb18B6 inhibited biofilm formation
by S. epidermidis RP62A to 60% of the maximum, while MAb25C11
and MAb20B9 enhanced the biofilm accumulation (Figure 3). The
effects of the MAbs on biofilm formation by other laboratory and
clinical strains of S. epidermidis were further deciphered. MAB18B6
exhibited obvious biofilm-inhibiting effect on RP62A, C328, and
C847, whereas it showed a mild effect on 1457 and C408.
MAb25C11 and MAb20B9 enhanced the biofilm formation by
RP62A, 1457, and C408, whereas they weakly inhibited the
biofilm formation by C328 and C847 (Table 4). Additionally, anti-
AapBrpt1.5 MAbs showed little effect on biofilm formation or
planktonic aggregation of biofilm-negative strains (Table 4).
The anti-AapBrpt1.5 MAbs recognize different epitopes
The presumed critical sites of Aap to mediate intercellular
adhesion are thought to be two histidine residues (His76 and His86)
in AapBrpt constructs (marked with triangles in Figure 2E) [22],
and the binding sites of our MAbs were determined to be nearby
these His residues (Figure 2D, E). Because there is no structural
report on the AapBrpt construct, it is difficult to determine how
these MAbs affect Aap dimerization by binding to their epitopes.
Nevertheless, the biofilm-inhibiting activity of the MAbs should be
related to their binding sites. MAb18B6 showed efficient biofilm-
inhibiting activity, and its epitope was found in all AapBrpt
constructs from S. epidermidis RP62A. MAb25C11 and MAb20B9
exhibited less biofilm inhibition than MAb18B6, and their epitopes
were found in only six constructs of AapBrpt while the other
constructs possessed two amino acid substitutions (V75H76 to
T75E76) (Figure 2E). In addition, the substitution of V75H76 by
T75E76 in an truncated AapBrpt1.5 fragment (TF1–102) obviously
reduced the interaction between the fragment and MAb25C11 and
MAb20B9 (especially for MAb25C11, Figure 9), providing further
support that MAb25C11 and MAb20B9 does not bind to Brpt
constructs with the V75H76 substituted and they cannot block Aap
dimerization completely.
The anti-AapBrpt1.5 MAbs affect Aap expression, eDNA
release, and PIA synthesis and enhance the bacterial
accumulation
To investigate the reasons for the biofilm-enhancing activities of
MAb25C11 and MAb20B9, Aap expression in S. epidermidis RP62A
co-cultured with the MAbs were further studied. Detecting by
Western blot and immunofluorescence, Aap expression in
planktonic cells and superficial biofilm bacteria treated with the
MAbs was found to be up-regulated, while the expression in
bacteria in profound layers of the biofilm was down-regulated
(Figure 5, 6, 7 and Table 2, 3). Although the bacteria in superficial
layers of the biofilm co-incubated with the MAbs expressed more
Aap (to 2,4 fold, Table 3), the obviously reduced Aap expression
in profound layers (to 0.1,0.2 fold, Table 3) was consistent with
the down-regulated biofilm Aap expression detected by Western
blot (Figure 5). The up-regulated Aap expression in planktonic and
superficial biofilm cells could mediate increased intercellular
adhesion, which aggregated the planktonic bacteria to form cell
clusters and further assisted more cells to accumulate on the
biofilm surface. Therefore, the biofilm cultured with the MAbs was
thicker (6.5–10.5 mM) than that without treatment (4.5 mM).
Moreover, the thickened boundaries of the crater-like micropores
(Figure 3C) in MAb18B6-treated biofilm may also relate to the
local up-regulated Aap expression (Figure 7). In addition to Aap
expression, eDNA release (Figure 8A, B, C) and PIA synthesis
(Figure 8D) were also up-regulated in bacteria co-cultured with
the MAbs, resulting in further enhanced bacterial accumulation.
Therefore, the up-regulated Aap expression, eDNA release and
PIA synthesis enhanced the biofilm formation.
Two contradictory actions of the MAbs on biofilm
formation
Up to now, we have revealed two contradictory actions of the
MAbs on biofilm formation. For one, the MAbs block Aap di-
merization by binding to AapBrpt constructs and thereby inhibit
bacterial accumulation and biofilm formation, and the effect is
decreased with time due to degradation of the MAbs. For the
other, the MAbs up-regulate Aap expression and EPS biosynthesis
of the bacteria, which result in enhanced bacterial accumulation
and biofilm formation, and the effect should be, contrarily, evoked
and increased with time.
Overall, the resultant effect of the MAbs on biofilm formation is
attributed to the counteraction between these two actions. At the
early phase of culture, MAb18B6 binds to all twelve AapBrpt
constructs and then significantly inhibits Aap dimerization and
bacterial accumulation (Figure 10A). With its inhibition of Aap
dimerization overwhelming the action of up-regulated Aap
expression and EPS biosynthesis (Figure 10B), MAb18B6 inhibits
Table 2. Fluorescence quantities of the immuno-probed
planktonic cells.
a
MAbs SYTO9
b Cy3
c Cy3/SYTO9
d
18B6 234.9 168.1 0.716
25C11 267.2 135.0 0.505
20B9 255.6 184.8 0.723
Mock 71.8 19.5 0.272
- 133.3 32.8 0.246
a. The planktonic cells of S. epidermidis RP62A and Aap were stained by SYTO9
and Cy3, respectively. After obtaining the fluorescence photomicrographs
under a CLSM (Figure 6), the fluorescence quantities of SYTO9-stained cells and
Cy3-stained Aap were determined using ImageJ program.
b. ‘‘SYTO9’’ stands for the fluorescence quantities of SYTO9-stained cells.
c. ‘‘Cy3’’ stands for the fluorescence quantities of Cy3-stained Aap.
d. ‘‘Cy3/SYTO9’’ represents the proportion of Aap in the cells.
doi:10.1371/journal.pone.0020918.t002
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six of the AapBrpt constructs and block Aap dimerization
incompletely (Figure 10A). Consequently, their weak inhibition
of Aap dimerization fail to overcome the action of up-regulated
Aap expression and EPS biosynthesis (Figure 10C), MAb25C11 and
MAb20B9 show little inhibition on biofilm formation. When it
comes to the late phase, the MAbs almost have been degraded
completely, and the up-regulated Aap expression and EPS
biosynthesis starts to play a leading role, which aggregates the
planktonic to form cell clusters (at 9 h post-incubation) and
enhances the biofilm formation (Figure 10B, C).
Therefore, at 14 h post-incubation, the bacteria co-cultured
with MAb18B6 shows weaker biofilm production, resulting from
slight reinforcement of the biofilm development which has been
severely suppressed in early phase (Figure 10B). Meanwhile, due to
the weak inhibition of Aap dimerization in early phase and the
intense up-regulation of Aap expression and EPS biosynthesis
(especially for eDNA release) in late phase, MAb25C11 and
MAb20B9 eventually lead to an enhanced biofilm formation
(Figure 10C). By dynamic monitoring the biofilm formation, we
found that the kinetic biofilm formation of the bacteria co-culture
with the MAbs is in agreement with our models described above.
The inhibited biofilm development of the bacteria co-cultured
with MAb18B6 was slightly reinforced after 12 h post-incubation,
while the uninhibited biofilm formation of the bacteria co-cultured
with MAb25C11 and MAb20B9 was strengthened after 10 h post-
incubation (Figure 10D).
The enhancement of S. epidermidis biofilm formation by anti-Aap
MAbs was also reported by Broekhuizen and et al [37]. They found
that the MAbs may increase rather than reduce binding of S.
epidermidis to biomaterials in an in vivo model. These antibodies
may have similar characteristics to our MAbs, which enhance the
biofilm formation by up-regulating Aap expression and EPS
biosynthesis. Considering those findings, vaccine development
using Aap as the antigen should pay attention to the following
points: which is the optimum epitope that mediate the highest
inhibition of Aap dimerization; how to reduce the effect of anti-
Aap antibodies on up-regulating Aap expression and EPS
biosynthesis.
In conclusion, in addition to our novel findings on the altered
Aap expression and EPS biosynthesis in S. epidermidis mediated by
mouse MAbs against Aap, the epitope mapping of biofilm-
affecting MAbs will, for the first time, contribute to a better
understanding of staphylococcal biofilm formation and help to
develop epitope-peptide vaccines against staphylococcal infections.
Materials and Methods
Ethics statement
All procedures performed on mice were conducted according to
relevant national and international guidelines (the Regulations for
the Administration of Affairs Concerning Experimental Animals,
China, and the NIH Guide for the Care and Use of Laboratory
Animals) and were approved by the Institutional Animal Care and
Use Committee (IACUC) of Shanghai Medical College, Fudan
University (IACUC Animal Project Number: 20090613-qu).
Materials
Prokaryotic vectors expressing AapBrpt1.5 and its truncated
forms were pSJ8 (MBP-His fusion vector) and pET28a (+),
respectively. The DNA fragment encoding GB1 tag [24,25,26]
which fused at the N-terminal of the truncated AapBrpt1.5 was
cloned from pETMG (GB1-His fusion vector). MAbs against
Figure 7. Aap expression in biofilms of S. epidermidis. Aap in the biofilms of S. epidermidis RP62A was probed with MAb25C11 (10 ng/mL) and
Cy3-conjugated secondary antibody (1:100 diluted, red fluorescence), and the bacteria were further stained with SYTO9 (1 mM, green fluorescence).
Aap expression was observed under a Leica TCS SP5 CLSM. Confocal microscopy Z-series of the biofilms were acquired in 0.5-mm increments. ‘‘PC’’:
positive control (antigens contained in the biofilm were probed using mouse anti-S. epidermidis serum (1:400 diluted) and Cy3-conjugated secondary
antibody, showing that antibodies could diffuse to the inner side of the biofilm), ‘‘NC’’: negative control (the biofilm formed in the presence of
MAb25C11 was probed with Cy3-conjugated secondary antibody alone to establish that the MAb-treated biofilms no longer contained initially added
MAb (10 mg/mL), that could cause false-positive immunofluorescence, after 14 h culture), ‘‘RP62A’’: untreated, ‘‘Mock’’: normal mouse IgG-treated, the
red arrow indicates the crater-like micropores.
doi:10.1371/journal.pone.0020918.g007
Table 3. Fluorescence quantities of the immuno-probed
biofilms.
a
MAbs Z-position (mm) SYTO9
b Cy3
c Cy3/SYTO9
d
18B6
e 0.5 1382.8 99.0 0.072
2.0 1668.6 127.7 0.077
3.5 1797.4 365.1 0.203
5.0 1666.0 797.7 0.479
6.5 984.7 630.4 0.640
25C11 0.5 1043.1 43.1 0.041
2.0 1250.7 107.5 0.086
3.5 1253.3 356.2 0.284
5.0 739.8 402.5 0.544
6.5 218.4 163.3 0.748
20B9 0.5 764.2 23.0 0.030
3.0 907.8 44.3 0.049
5.5 735.8 165.8 0.225
8.0 417.7 295.3 0.707
10.5 151.4 194.1 1.282
Mock 0.5 712.1 211.6 0.297
1.5 779.8 225.8 0.290
2.5 803.9 245.7 0.306
3.5 559.5 165.7 0.296
4.5 201.1 51.8 0.258
- 0.5 1040.6 378.5 0.364
1.5 1133.4 415.2 0.366
2.5 950.4 345.5 0.364
3.5 399.6 129.1 0.323
4.5 128.2 37.6 0.293
a. The biofilm of S. epidermidis RP62A and Aap were stained by SYTO9 and Cy3,
respectively. After obtaining the fluorescence photomicrographs under a CLSM
(Figure 7), the fluorescence quantities of SYTO9-stained cells, Cy3-stained Aap
were determined using ImageJ program.
b. ‘‘SYTO9’’ stands for the fluorescence quantities of SYTO9-stained cells.
c. ‘‘Cy3’’ stands for the fluorescence quantities of Cy3-stained Aap.
d. ‘‘Cy3/SYTO9’’ represents the proportion of Aap in the biofilms.
e. Fluorescence quantities of SYTO9 and Cy3 in biofilm co-cultured with
MAb18B6 were obtained from other images (not shown) which captured at the
area away from the boundaries of the crater-like micropores where Cy3-stained
Aap was up-regulated in all Z-positions.
doi:10.1371/journal.pone.0020918.t003
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PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e20918Figure 8. EPS biosynthesis in biofilm of S. epidermidis. (A) Extracellular DNA quantification. Extracellular DNA was isolated from the biofilm
matrices of S. epidermidis RP62A, and Q-PCRs of four chromosomal loci (gyrA (gyrase A), serp0306 (ferrichrome transport ATP-binding protein A), lysA
(diaminopimelate decarboxylase A), and leuA (2-isopropylmalate synthase)) were performed for eDNA quantification in each biofilm. The biomass
that represented the biofilm density was quantified at A600, and the eDNA measurement was normalized to biofilm biomass as described previously
[27]. Data are depicted as averages of three Q-PCR detections with the standard deviation, and the results represent one of three independent
experiments. (B, C) Biofilm stability against DNase treatment. When exposed to DNase I (0.14 U/mL), the biofilm was more severely disintegrated in
the presence of each MAb compared with that formed in the absence of the MAbs. The data are means 6 SD of three independent experiments. The
biofilm density ratios of the untreated biofilms and biofilms treated with DNase I were plotted (C). (D) PIA synthesis in biofilm of S. epidermidis. PIA
synthesis in biofilm of S. epidermidis RP62A was detected using the WGA-HRP dot blot assay. Serial dilutions of the PIA extractions from biofilm
bacteria were spotted onto nitrocellulose transfer membranes, and the HRP activity was visualized using chromogenic detection. The data represent
one of three independent experiments. ‘‘RP62A’’: untreated; ‘‘Mock’’: normal mouse IgG-treated.
doi:10.1371/journal.pone.0020918.g008
Table 4. Effects of anti-AapBrpt1.5 MAbs on different S. epidermidis strains.
Strain general features Relative biofilm formation (%)
a Planktonic aggregation
b
Strains ica Biofilm formation
c Planktonic aggregation
d MAb18B6 MAb25C11 MAb20B9 MAb18B6 MAb25C11 MAb20B9
RP62A ++ + 2 66.8 120.0 132.8 +++ +++ +++
1457 ++ + 2 84.0 151.3 143.8 +++ +++ +++
C408
e ++ + 2 91.5 107.9 122.5 +++
C328
e ++ + 2 70.0 83.9 97.7 +++ +++ +++
C847
e ++ + 53.8 64.8 67.3 ++ ++ ++
C698
e ++ /2 2 222222
12228 2 2 2 222222
a. ‘‘Relative biofilm formation’’ of the strains cultured in the presence of each MAb (10 mg/mL) in polystyrene plates was calculated by dividing the mean density of
MAb-treated biofilms by that of untreated biofilms. ‘‘-’’ means no biofilm formation was observed.
b. Planktonic aggregation of the strains statically cultured in the presence of each MAb (10 mg/mL) was described using ‘‘+++’’, ‘‘++’’, ‘‘+’’, or ‘‘2’’, which means that very
many, many, a few, or no bacterial clusters were observed, respectively.
c. Biofilm formation by the strains without treatment was described using ‘‘++’’, ‘‘+’’, ‘‘+/2’’, or ‘‘2’’, which means that strong, weak, slight, or no biofilm formation was
observed in polystyrene plates, respectively.
d. Cell aggregation of the strains without treatment was described using ‘‘+’’ or ‘‘2’’, which means that a few or no bacterial clusters were observed, respectively.
e. The clinical strains of S. epidermidis were obtained from Zhongshan Hospital and Ruijin Hospital, Shanghai, China.
doi:10.1371/journal.pone.0020918.t004
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http://www.ab-mart.com). S. epidermidis strains RP62A and
ATCC 12228 were purchased from the American Type Culture
Collection (ATCC, http://www.atcc.org), S. epidermidis strain 1457
was kindly provided by Dr. Yicun Gao from Hong Kong
University, and clinical strains of S. epidermidis were isolated from
patient samples from Zhongshan Hospital and Ruijin Hospital in
Shanghai, China. All of the oligonucleotide primers used in this
study are listed in Table 5.
Expression and purification of recombinant AapBrpt1.5
The gene coding for AapBrpt1.5 (amino acids 1088–1296,
GenBank NP_763730) was PCR-amplified from genome of S.
epidermidis ATCC 12228. AapBrpt1.5 was expressed as a fusion
protein with an N-terminal maltose-binding protein-tagged six-
histidine (MBP-His) tag. The MBP-His-tagged AapBrpt1.5 was
purified using a Ni-NTA column (Qiagen, http://www.qiagen.
com) and then cleaved using TEV protease. The un-tagged
AapBrpt1.5 was further purified using Ni-NTA and Superdex 75
gel filtration columns (GE Healthcare, http://www.gehealthcare.
com). The molecular mass of the untagged AapBrpt1.5 was
verified using the LC/ESI-MS system (Agilent, http://www.
agilent.com, and Thermo Finnigan, http://www.thermoscientific.
com).
Expression of truncated AapBrpt1.5
To perform the epitope mapping for the anti-AapBrpt1.5
MAbs, AapBrpt1.5 was truncated using the following methods.
Briefly, AapBrpt1.5 was first N-terminally fused with a GB1-
tagged six-histidine (GB1-His) tag [24,25,26], and the DNA
fragment coding for truncated AapBrpt1.5 with the N-terminal
GB1-His tag was then amplified using PCR and further cloned
into vector pET28a(+) to be used for expression of the truncated
fragments.
Immunoprecipitation
The purified proteins were diluted in lysis buffer containing
20 mM Tris-HCl (pH 8.0), 137 mM NaCl, 1 mM EDTA, 1%
(vol/vol) Triton X-100, and protease inhibitors for non-denaturing
buffer conditions or 1% (wt/vol) SDS, 5 mM EDTA, 10 mM
beta-mercaptoethanol, and protease inhibitors for denaturing
buffer conditions. The samples for the denaturing immunoprecip-
itation were further diluted with the non-denaturing lysis buffer.
The immunoprecipitation was performed using the MAbs and
protein G-coupled Sepharose beads (Santa Cruz, http://www.
scbt.com). Normal mouse IgG (Santa Cruz, http://www.scbt.com)
was used as the negative control. After the immunoprecipitation,
the beads were washed with the non-denaturing lysis buffer and
boiled in SDS sample buffer, and a rabbit anti-His-tag antibody
(Cell Signaling Technology, http://www.cellsignal.com) was used
to detect the immunoprecipitated proteins.
Western blot
Bacterial lysates and immunoprecipitated samples were pre-
pared in SDS sample buffer, and the proteins contained in the
samples were separated using SDS-PAGE (7% or 12%). Separated
proteins were further electrotransferred onto a polyvinylidene
fluoride (PVDF) membrane (Millipore, http://www.millipore.
com) and probed with the corresponding primary antibodies:
anti-AapBrpt1.5 MAbs (1 ng/mL) or rabbit anti-His-tag antibody.
After incubation with the HRP-conjugated secondary antibody
(Santa Cruz, http://www.scbt.com), the immunoreactivity of the
membranes was visualized using an ECL Western blotting system
(Thermo, http://www.thermo.com).
Detection of biofilm formation
Biofilm formation was detected using a semiquantitative plate
assay [38]. An overnight culture of S. epidermidis grown in TSB was
diluted 1:200 into fresh TSB containing dilutions of mouse serum
or MAbs, and statically incubated in 96-well polystyrene plates
(Corning, http://www.corning.com), initially at 4uC for 2 h and
then at 37uC for 14 h. After incubation, the wells were washed
with PBS, fixed with methanol, and stained with 2% (wt/vol)
crystal violet. The absorbance of the wells was determined at
570 nm using a 96-well plate spectrophotometer (Beckman
Coulter DTX880, http://www.beckmancoulter.com). For micro-
scopic observation of biofilm formation, S. epidermidis biofilms were
further cultivated in FluoroDishes (FD35-100, WPI, http://www.
wpiinc.com) [28], stained with a Live/Dead kit (containing
SYTO9 and PI, Invitrogen, http://www.invitrogen.com), and
Figure 9. The substitution of V75H76 by T75E76 in TF1–102 reduced the interaction between the fragment and MAb25C11 and MAb20B9.
The AapBrpt1.5 fragment, TF1–102, with the substitution of V75H76 by T75E76 was established using site-directed mutagenesis. The interactions
between the mutated fragment and MAb25C11 and MAb20B9 were detected using immunoprecipitation. ‘‘TF1–102V75H76’’: wild type, ‘‘TF1–102T75E76’’:
mutant, ‘‘IgG H’’: IgG heave chain.
doi:10.1371/journal.pone.0020918.g009
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CLSM, Leica, http://www.leica-microsystems.com).
Disintegrating treatment of the biofilms and the bacterial cell
clusters were tested as published elsewhere [17,27,39,40]. The
biofilms were formed in the presence of 0.14 U/mL DNase I
(Takara, http://www.takara-bio.com) for 14 h, and then washed
with PBS, fixed with methanol, and stained with 2% (wt/vol)
crystal violet. For disintegrating treatment of the bacterial clusters,
the clusters were treated with 0.1 mg/mL proteinase K (Merck,
http://www.merck.com), 20 mM Tris (pH 7.5), 100 mM NaCl
Figure 10. Contradictory actions of the MAbs on biofilm formation. (A) Model for MAbs affecting Aap dimerization. According to the zinc
zipper model for intercellular adhesion mediated by zinc-dependent Aap dimerization [22], we speculate that MAb18B6 binds to all twelve AapBrpt
constructs and significantly inhibits Aap dimerization, whereas MAb25C11 and MAb20B9 bind to six of the AapBrpt constructs and block Aap
dimerization incompletely. (B, C) Model for MAbs affecting bacterial accumulation. The resultant effect (black curves) of the MAbs on bacterial
accumulation is attributed to the counteraction between two contradictory actions, one inhibits biofilm formation by binding to Aap (blue bars), and
the other enhances bacterial accumulation by up-regulating Aap expression and EPS biosynthesis (red bars). (D) Kinetic studies on biofilm formation.
The cells of S. epidermidis RP62A were co-cultured with 10 mg/mL of each MAb in 96-well polystyrene plates initially at 4uC for 2 h, and then at 37uC
for 2 h, 4 h, 6 h, 8 h, 10 h, 12 h, and 14 h, respectively. After incubation, biofilm formation at different time points was measured using crystal violet
staining, and the results are depicted as means 6 SD of three independent experiments.
doi:10.1371/journal.pone.0020918.g010
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sodium acetate (pH 4.5) for 6 h at 37uC, or 0.2 U/mL DNase I in
PBS for 6 h at 37uC.
RNA extraction and quantitative RT-PCR
After static incubation at 37uC for 14 h in 50-mm polystyrene
dishes, S. epidermidis cells (planktonic and biofilm) were collected
and washed with ice-cold saline, and then homogenized using
0.1 mm Ziconia-silica beads in Mini-Beadbeater (Biospec, http://
www.biospec.com) at a speed of 4800 rpm. The bacterial RNA
was isolated using an RNeasy kit (QIAGEN, http://www.qiagen.
com) according to its standard protocol. The relative expression
level of the aap gene was determined by quantitative RT-PCR with
gene-specific primers listed in table 5.
Immunofluorescence assay
Biofilms of S. epidermidis RP62A were cultured on glass
coverslips. After static co-incubation with or without the MAbs
at 4uC for 2 h initially and then at 37uC for 14 h, the coverslips
with the biofilms were washed gently with PBS, fixed with
methanol, and blocked with 3% (wt/vol) bovine serum albumin
(BSA) in PBS for 4 h at room temperature. Antigens contained in
the biofilms were primarily probed with 10 ng/mL MAb25C11 or
1:400 diluted mouse anti-S. epidermidis serum and secondarily
probed with Cy3-conjugated goat anti-mouse secondary antibody
(Jackson ImmunoResearch, http://www.jacksonimmuno.com).
After three washes with PBS, the biofilms were further stained
with SYTO9 (1 mM, Invitrogen, http://www.invitrogen.com).
The antigen distribution was observed under a Leica TCS SP5
CLSM.
PIA quantification
PIA was quantified as previously described [30,31,32]. In
brief, after static incubation at 37uC for 14 h in 35-mm poly-
styrene dishes, S. epidermidis cells were scraped off and re-
suspended in 0.5 M EDTA (pH 8.0). After treatment with
proteinase K (4 mg/ml; Merck, http://www.merck.com) for
3h o u r sa t3 7 uC, serial dilutions of the PIA extracts were spotted
onto nitrocellulose transfer membranes (Millipore, http://www.
millipore.com). The air-dried membrane was blocked with 3%
(wt/vol) BSA and subsequently incubated with 3.2 mg/mL
horseradish peroxidase-coupled wheat germ agglutinin (WGA-
HRP conjugate; Lectinotest Laboratory, National Medical Uni-
versity in Lviv, Ukraine) for 1 h. HRP activity was visualized
using chromogenic detection.
Extracellular DNA quantification
The isolation of eDNA from biofilms was performed as
described previously [27,28,29]. After static incubation at 37uC
for 14 hours, the 96-well polystyrene plates were chilled at 4uC,
and EDTA was added to each well to a final concentration of
2.5 mM. The supernatants were discarded, and the unwashed
biofilms were harvested by resuspension in 50 mM Tris-HCl
(pH 8.0), 10 mM ETDA, and 500 mM NaCl. After centrifuga-
tion, the supernatant was diluted in 10 mM Tris-HCl (pH 8.0),
1.0 mM EDTA (TE) and extracted with phenol/chloroform/
isoamyl alcohol (25:24:1) and chloroform/isoamyl alcohol
(24:1). DNA in the aqueous phase of each sample was then
extracted using ethanol precipitation and dissolved in TE buffer.
Quantitative PCRs were performed using SYBR Premix Ex Taq
(Takara, http://www.takara-bio.com) on 1:10 dilutions of each
sample using the four primer sets listed in Table 5.
Triton X-100-induced autolysis
Autolysis of S. epidermidis RP62A treated with the MAbs was
analyzed according to previously published methods [41]. An
overnight culture of S. epidermidis RP62A was diluted 1:200 into
fresh TSB supplemented with 0.1 mM NaCl and 10 mg/mL
MAbs and incubated at 4uC for 2 h then shaken at 37uC until the
A600 reached 0.8. The collected bacteria were washed with
distilled water and resuspended in 50 mM Tris-HCl (pH 7.2),
and 0.05% (vol/vol) Triton X-100. The resuspended bacteria
were shaken at 30uC for an additional 2 h, and autolysis was
monitored by measuring the turbidity of the suspension at A600
every 15 min.
Table 5. Oligonucleotide primers used in the present study.
Primers Sequence (59R39)
Primers used for PCR amplification of AapBrpt1.5
a
F CGCGGATCCCCAGTTGATGGAGATCCGATTAC
R CCGCTCGAGTTATTTTGTTGGACCATACTCAACAATT
Primers used for Q-PCRs in eDNA quantification
b
gyrA F CCTTATGAAACTCGGAGATGG
gyrA R TCAGTAGTAGTAGATTGTTGCG
serp0306 F ATGCCACATCCACGAAAGA
serp0306 R TGTAACTGACAATGCCCAATC
lysA F TGACAATGGGAGGTACAAGC
lysA R TGGTCTTCATCGTAAACAATCG
leuA F GTGAACGGTATTGGTGAAAGAG
leuA R GTGGTCCTTCCTTACATATAAAGC
Primers used for Q-RT-PCRs in Aap transcriptional analysis
b
gyrB F AGAAGAGGAAGTTAGAGAAGA
gyrB R GCATATCCACTGTTATATTGAAG
aap F ACGAGGAATTACAATCATCA
aap R GTAGTTGGCGGTATATCTATT
Primers used for truncation of the GB1-His-tagged AapBrpt1.5
F
c CATGCCATGGGCATGCAGTACAAGCTTGCTCTGAACG
TF1–160 R
a CCGCTCGAGTTAAACGCGCTCTTCACCTGGTTTTAAA
TF1–102 R
a CCGCTCGAGTTAAACTTCAGTTTTACTATCTACAGGTGCA
TF1–53 R
a CCGCTCGAGTTATGTTAATGGGTTCTTAGTTGTTGGC
TF1–132 R
a CCGCTCGAGTTAACCAACTTTCGGACCATATTTTGT
TF1–122 R
a CCGCTCGAGTTAATCCACTGGTGGGGTAACAACT
TF1–112 R
a CCGCTCGAGTTAATCAGGATTTTTAACTCCTGGTTTA
TF1–90 R
a CCGCTCGAGTTAAAATTCATCTTTATGACCTTGTGGTAT
TF1–80 R
a CCGCTCGAGTTATTCACCACCATAATGAACAATCTCAT
TF1–70 R
a CCGCTCGAGTTATGGTTGTTTTGTTATTTTTTCTGTTGG
TF1–60 R
a CCGCTCGAGTTAACCTTCGCCAACTTTTTCTCCTGTT
Primers used for site-directed mutagenesis of the GB1-His tagged TF1–102
F
a ACAACCAGTGGATGAGATTACTGAATATGGTGGTGAACAAATACC
R
a GGTATTTGTTCACCACCATATTCAGTAATCTCATCCACTGGTTGT
a. Primers were designed according to the genomic sequence of S. epidermidis
ATCC 12228 (GenBank NC_004461).
b. Primers were designed according to the genomic sequence of S. epidermidis
RP62A (GenBank NC_002976).
c. Primers were designed according to the gene sequence of the 56-residue B1
immunoglobulin binding domain (GB1) of immunoglobulin G-binding protein
from Streptococcus dysgalactiae subsp. equisimilis GGS_124 (amino acids
303–357, GenBank YP_002997067).
doi:10.1371/journal.pone.0020918.t005
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Site-directed mutagenesis was performed with the QuikChange
site-directed mutagenesis kit (Stratagene, Agilent Technologies,
http://www.genomics.agilent.com), using the plasmid used for
expression of the truncated AapBrpt1.5 fragment TF1–102 as a
template. The primers used for the mutant (V75H76 to T75E76) are
listed in Table 5. The mutant plasmid was confirmed by DNA
sequencing before being transformed into E. coli strain BL21(DE3).
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